Mohr, Davidow Ventures has raised $580 million for its ninth fund, according to a regulatory filing. It is unclear whether or not this represents a final close, as Private Equity Insider previously had reported that the firm was seeking between $500 million and $600 million. Its previous fund closed on $400 million in 2005. www.mdv.com
Stone Point Capital has entered into a strategic relationship with Mitsui & Co., in order to pursue investments in the Japanese insurance and financial services markets. www.stonepointcapital.com
InterWest Partners has promoted Linda Grais to the position of partner. She joined the firm in 2005 as an executive-in-residence, and focuses on opportunities in the biopharmaceutical and medical device space. Her current board seats include Gynesonics and Arca Discovery. www.interwest.com
Henry Wang has joined Citigroup Global Markets as a vice president in the firm's Financial Entrepreneurs group. He previously was a vice president with Financial Technology Partners. www.citigroup.com
Rahul Jain has joined Core Capital Partners as an associate. He previously served in various marketing, product management and business development roles with 3Com. www.core-capital.com
Vestar Capital Partners has named Kevin Mundt as president of Vestar Resources, the firm's in-house strategic counsel resource for portfolio company management teams. Mundt joined Vestar Resources in 2004 as a managing director.
Houlihan Lokey has named Sandy Purcell and Jean-Florent Rerolle as co-heads of the firm's European Financial Advisory Services (FAS) practice. Purcell is a managing director in the firm's London office, and previously headed its Mideast FAS practice. Rerolle is a managing director based in France. www.hlhz.com
Xangati, a Cupertino, Calif.-based provider of rapid problem identification (RPI) applications for enterprise networks, has raised $10.7 million in Series B funding. Walden International led the deal, with partner Mary Coleman joining the board of directors. Return backer Alloy Ventures also participated. www.xangati.com
Cellerix SL, a Tres Cantos, Spain-based developer of adult stem cell therapies, has raised EUR 27.2 million in new VC funding. Life Sciences Partners and Ventech co-led the round, and were joined by Roche Venture Fund, Novartis Venture Fund and Ysios Capital Partners. Return backers included former parent company Genetrix and Grupo A&G. www.cellerix.com
JapanBridge Inc., a Tokyo-based drug company, has raised $6.5 million in Series A-2 funding. Return backers MPM Capital and Itochu were joined by new strategic partner Kyowa Hakko Kogyo Co. Ltd., which will collaborate with JapanBridge on the commercialization of oncology and oncology supportive care assets in Japan. www.japanbridge.co.jp